Enovix (NASDAQ:ENVX) Sets New 52-Week Low – Here’s What Happened

Enovix Corporation (NASDAQ:ENVX)’s share price reached a new 52-week low on Thursday . The company traded as low as $4.42 and last traded at $4.4350, with a volume of 1505771 shares. The stock had previously closed at $4.68.

Analysts Set New Price Targets

Several analysts have recently issued reports on ENVX shares. JPMorgan Chase & Co. cut shares of Enovix from a “neutral” rating to an “underweight” rating in a research report on Wednesday, May 6th. Wall Street Zen upgraded Enovix from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 16th. Weiss Ratings reissued a “sell (e+)” rating on shares of Enovix in a research note on Wednesday, July 8th. TD Cowen decreased their price objective on Enovix from $7.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday. Finally, Craig Hallum decreased their price objective on Enovix from $10.00 to $8.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. Six investment analysts have rated the stock with a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $12.50.

Enovix Price Performance

The company has a debt-to-equity ratio of 2.14, a current ratio of 10.97 and a quick ratio of 10.65. The firm has a market cap of $861.69 million, a P/E ratio of -4.76 and a beta of 2.26. The stock’s 50-day simple moving average is $6.21 and its two-hundred day simple moving average is $6.25.

Enovix (NASDAQ:ENVX) last announced its earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.01. The business had revenue of $7.60 million for the quarter, compared to the consensus estimate of $6.95 million. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The business’s revenue for the quarter was up 49.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.15) earnings per share. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Equities research analysts forecast that Enovix Corporation will post -0.79 earnings per share for the current fiscal year.

Institutional Trading of Enovix

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd bought a new stake in Enovix in the fourth quarter worth about $30,000. Parallel Advisors LLC grew its stake in shares of Enovix by 51.9% during the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock valued at $39,000 after buying an additional 1,342 shares during the last quarter. CWM LLC raised its holdings in shares of Enovix by 95.4% in the fourth quarter. CWM LLC now owns 6,081 shares of the company’s stock worth $44,000 after buying an additional 2,969 shares during the period. Calamos Advisors LLC purchased a new stake in shares of Enovix in the first quarter worth approximately $60,000. Finally, Gateway Wealth Partners LLC purchased a new stake in shares of Enovix in the first quarter worth approximately $68,000. 50.92% of the stock is owned by hedge funds and other institutional investors.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.